Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | ALKS |
---|---|---|
09:32 ET | 107300 | 23.27 |
09:34 ET | 19692 | 23.705 |
09:36 ET | 7425 | 24.02 |
09:38 ET | 41863 | 23.96 |
09:39 ET | 12021 | 23.975 |
09:41 ET | 14405 | 23.74 |
09:43 ET | 10330 | 23.66 |
09:45 ET | 24670 | 23.47 |
09:48 ET | 11734 | 23.49 |
09:50 ET | 20165 | 23.505 |
09:52 ET | 14457 | 23.65 |
09:54 ET | 38029 | 23.68 |
09:56 ET | 6207 | 23.57 |
09:57 ET | 11032 | 23.58 |
09:59 ET | 18651 | 23.61 |
10:01 ET | 25734 | 23.71 |
10:03 ET | 11284 | 23.885 |
10:06 ET | 38758 | 23.715 |
10:08 ET | 4095 | 23.705 |
10:10 ET | 12197 | 23.5 |
10:12 ET | 47103 | 23.66 |
10:14 ET | 13465 | 23.85 |
10:15 ET | 5535 | 23.735 |
10:17 ET | 7372 | 23.8 |
10:19 ET | 9913 | 23.78 |
10:21 ET | 10503 | 23.825 |
10:24 ET | 5097 | 23.76 |
10:26 ET | 5200 | 23.83 |
10:28 ET | 6130 | 23.78 |
10:30 ET | 10174 | 23.82 |
10:32 ET | 16220 | 23.55 |
10:33 ET | 16138 | 23.53 |
10:35 ET | 4593 | 23.65 |
10:37 ET | 6070 | 23.84 |
10:39 ET | 10156 | 23.91 |
10:42 ET | 3048 | 23.87 |
10:44 ET | 1400 | 23.9 |
10:46 ET | 1103 | 23.9 |
10:48 ET | 4550 | 23.8 |
10:50 ET | 3513 | 23.88 |
10:51 ET | 6958 | 23.97 |
10:53 ET | 3761 | 23.985 |
10:55 ET | 1448 | 23.91 |
10:57 ET | 5200 | 23.92 |
11:00 ET | 2400 | 23.91 |
11:02 ET | 6077 | 23.805 |
11:04 ET | 4140 | 23.87 |
11:06 ET | 945 | 23.825 |
11:08 ET | 13233 | 23.965 |
11:09 ET | 10444 | 24.09 |
11:11 ET | 3323 | 24.13 |
11:13 ET | 19636 | 24.185 |
11:15 ET | 33502 | 24.13 |
11:18 ET | 16081 | 23.93 |
11:20 ET | 21658 | 23.76 |
11:22 ET | 22355 | 23.62 |
11:24 ET | 9646 | 23.725 |
11:26 ET | 12289 | 23.77 |
11:27 ET | 9264 | 23.78 |
11:29 ET | 3215 | 23.83 |
11:31 ET | 4896 | 23.78 |
11:33 ET | 1277 | 23.785 |
11:36 ET | 3220 | 23.8 |
11:38 ET | 6183 | 23.85 |
11:40 ET | 6376 | 23.79 |
11:42 ET | 2080 | 23.79 |
11:44 ET | 4681 | 23.81 |
11:45 ET | 4116 | 23.73 |
11:47 ET | 4995 | 23.72 |
11:49 ET | 1175 | 23.7 |
11:51 ET | 5565 | 23.64 |
11:54 ET | 900 | 23.62 |
11:56 ET | 3273 | 23.61 |
11:58 ET | 5463 | 23.65 |
12:00 ET | 5119 | 23.71 |
12:02 ET | 2700 | 23.67 |
12:03 ET | 4162 | 23.72 |
12:05 ET | 3138 | 23.7 |
12:07 ET | 4160 | 23.75 |
12:09 ET | 800 | 23.79 |
12:12 ET | 1000 | 23.78 |
12:14 ET | 1400 | 23.78 |
12:16 ET | 4718 | 23.78 |
12:18 ET | 7146 | 23.75 |
12:20 ET | 5393 | 23.77 |
12:21 ET | 450 | 23.76 |
12:23 ET | 6666 | 23.81 |
12:25 ET | 663 | 23.8199 |
12:27 ET | 1878 | 23.76 |
12:30 ET | 3110 | 23.76 |
12:32 ET | 1974 | 23.8 |
12:34 ET | 1897 | 23.81 |
12:36 ET | 900 | 23.805 |
12:38 ET | 21308 | 23.64 |
12:39 ET | 5082 | 23.615 |
12:41 ET | 5605 | 23.72 |
12:43 ET | 2439 | 23.7 |
12:45 ET | 1300 | 23.685 |
12:48 ET | 2643 | 23.64 |
12:50 ET | 1955 | 23.62 |
12:52 ET | 7812 | 23.58 |
12:54 ET | 4995 | 23.6201 |
12:56 ET | 1544 | 23.63 |
12:57 ET | 2834 | 23.69 |
12:59 ET | 2535 | 23.66 |
01:03 ET | 700 | 23.66 |
01:06 ET | 7924 | 23.605 |
01:08 ET | 3372 | 23.65 |
01:10 ET | 1500 | 23.68 |
01:12 ET | 100 | 23.68 |
01:14 ET | 2426 | 23.69 |
01:15 ET | 2441 | 23.74 |
01:17 ET | 3040 | 23.79 |
01:19 ET | 2864 | 23.8 |
01:21 ET | 1656 | 23.83 |
01:24 ET | 1833 | 23.79 |
01:26 ET | 3227 | 23.785 |
01:28 ET | 1626 | 23.8 |
01:30 ET | 1442 | 23.78 |
01:32 ET | 500 | 23.76 |
01:33 ET | 600 | 23.73 |
01:35 ET | 1400 | 23.72 |
01:37 ET | 3170 | 23.706 |
01:39 ET | 827 | 23.71 |
01:42 ET | 644 | 23.69 |
01:44 ET | 3852 | 23.64 |
01:46 ET | 900 | 23.63 |
01:48 ET | 2217 | 23.62 |
01:50 ET | 2007 | 23.6 |
01:51 ET | 800 | 23.61 |
01:53 ET | 5681 | 23.68 |
01:55 ET | 1867 | 23.64 |
01:57 ET | 310 | 23.63 |
02:00 ET | 1108 | 23.64 |
02:02 ET | 4324 | 23.59 |
02:04 ET | 2747 | 23.61 |
02:06 ET | 2832 | 23.62 |
02:08 ET | 3098 | 23.67 |
02:09 ET | 2638 | 23.68 |
02:11 ET | 2115 | 23.615 |
02:13 ET | 1850 | 23.61 |
02:15 ET | 2500 | 23.63 |
02:18 ET | 1400 | 23.62 |
02:20 ET | 2298 | 23.62 |
02:22 ET | 3530 | 23.66 |
02:24 ET | 3315 | 23.65 |
02:26 ET | 619 | 23.64 |
02:27 ET | 1955 | 23.68 |
02:29 ET | 300 | 23.685 |
02:31 ET | 4084 | 23.6 |
02:33 ET | 3319 | 23.7 |
02:36 ET | 5971 | 23.765 |
02:38 ET | 2988 | 23.83 |
02:40 ET | 3466 | 23.87 |
02:42 ET | 5737 | 23.87 |
02:44 ET | 5046 | 23.88 |
02:45 ET | 17770 | 23.95 |
02:47 ET | 43162 | 23.895 |
02:49 ET | 5389 | 23.83 |
02:51 ET | 5549 | 23.86 |
02:54 ET | 2899 | 23.85 |
02:56 ET | 3304 | 23.845 |
02:58 ET | 3428 | 23.835 |
03:00 ET | 14010 | 23.78 |
03:02 ET | 12621 | 23.87 |
03:03 ET | 31224 | 23.97 |
03:05 ET | 14219 | 23.96 |
03:07 ET | 13513 | 23.96 |
03:09 ET | 15660 | 23.89 |
03:12 ET | 17853 | 23.96 |
03:14 ET | 8952 | 23.92 |
03:16 ET | 14777 | 23.94 |
03:18 ET | 18464 | 24 |
03:20 ET | 19616 | 24.06 |
03:21 ET | 23138 | 24.17 |
03:23 ET | 22127 | 24.1375 |
03:25 ET | 21147 | 24.23 |
03:27 ET | 10258 | 24.22 |
03:30 ET | 19291 | 24.19 |
03:32 ET | 12378 | 24.2 |
03:34 ET | 13144 | 24.17 |
03:36 ET | 28324 | 24 |
03:38 ET | 12460 | 24.015 |
03:39 ET | 14721 | 24.08 |
03:41 ET | 19578 | 24.155 |
03:43 ET | 18953 | 24.155 |
03:45 ET | 20427 | 24.22 |
03:48 ET | 18494 | 24.235 |
03:50 ET | 23652 | 24.1 |
03:52 ET | 18616 | 24.055 |
03:54 ET | 16570 | 24.01 |
03:56 ET | 22504 | 24.03 |
03:57 ET | 24341 | 24.005 |
03:59 ET | 49097 | 24.01 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Alkermes Plc | 4.2B | 7.9x | --- |
Exelixis Inc | 6.9B | 33.9x | -21.77% |
Sinovac Biotech Ltd | 639.9M | -1.8x | +15.89% |
Halozyme Therapeutics Inc | 4.8B | 18.6x | --- |
PTC Therapeutics Inc | 2.5B | -4.4x | --- |
P3 Health Partners Inc | 169.7M | -0.9x | --- |
Alkermes plc is a global biopharmaceutical company that seeks to develop medicines in the field of neuroscience. The Company has a portfolio of commercial products for the treatment of alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder and a pipeline of clinical and preclinical candidates in development for neurological disorders. It focuses on commercial products, such as LYBALVI, ARISTADA/ARISTADA INITIO and VIVITROL, and advancing the development of pipeline programs focused on neurological disorders. LYBALVI is a once-daily, oral atypical antipsychotic drug for the treatment of adults with schizophrenia and for the treatment of adults with bipolar I disorder, as a maintenance monotherapy or for the acute treatment of manic or mixed episodes, as monotherapy or an adjunct to lithium or valproate. ARISTADA is an extended-release intramuscular injectable suspension for the treatment of schizophrenia. It has a manufacturing facility in Wilmington, Ohio.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $4.2B |
---|---|
Revenue (TTM) | $1.7B |
Shares Outstanding | 169.2M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.58 |
EPS | $3.02 |
Book Value | $7.20 |
P/E Ratio | 7.9x |
Price/Sales (TTM) | 2.5 |
Price/Cash Flow (TTM) | 7.0x |
Operating Margin | 24.90% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.